Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Nuclear Medicine/Radiopharmaceuticals Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • GLO2957712
  • 122 Pages
  • April 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Scope of the Report:

Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.

In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.

The worldwide market for Nuclear Medicine/Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Nuclear Medicine/Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Diagnostic

Therapeutic

Market Segment by Applications, can be divided into

Oncology

Thyroid

Cardiology

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceuticals in 2017 and 2018.

Chapter 3, the Nuclear Medicine/Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nuclear Medicine/Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Nuclear Medicine/Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Diagnostic

1.2.2 Therapeutic

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Thyroid

1.3.3 Cardiology

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 China Isotope & Radiation

2.1.1 Business Overview

2.1.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Dongcheng

2.2.1 Business Overview

2.2.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Jaco

2.3.1 Business Overview

2.3.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Ciaeriar

2.4.1 Business Overview

2.4.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Advanced Molecular-imaging Solution

2.5.1 Business Overview

2.5.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Shanghai Atom Kexing

2.6.1 Business Overview

2.6.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2018

3.3.2 Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Regions

4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Regions

4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Regions (2014-2019)

4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Regions (2014-2019)

4.2 North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.5 South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5 North America Nuclear Medicine/Radiopharmaceuticals by Country

5.1 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country

5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

5.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

5.2 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5.3 Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5.4 Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6 Europe Nuclear Medicine/Radiopharmaceuticals by Country

6.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country

6.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

6.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

6.2 Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.3 UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.4 France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.5 Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.6 Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals by Country

7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

7.2 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.4 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.5 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8 South America Nuclear Medicine/Radiopharmaceuticals by Country

8.1 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country

8.1.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

8.1.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

8.2 Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8.3 Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8.4 Colombia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries

9.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.3 Turkey Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.4 Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.5 Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.6 South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

10 Global Nuclear Medicine/Radiopharmaceuticals Market Segment by Type

10.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2014-2019)

10.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)

10.2 Diagnostic Sales Growth and Price

10.2.1 Global Diagnostic Sales Growth (2014-2019)

10.2.2 Global Diagnostic Price (2014-2019)

10.3 Therapeutic Sales Growth and Price

10.3.1 Global Therapeutic Sales Growth (2014-2019)

10.3.2 Global Therapeutic Price (2014-2019)

11 Global Nuclear Medicine/Radiopharmaceuticals Market Segment by Application

11.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2014-2019)

11.2 Oncology Sales Growth (2014-2019)

11.3 Thyroid Sales Growth (2014-2019)

11.4 Cardiology Sales Growth (2014-2019)

12 Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)

12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions (2019-2024)

12.2.1 North America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.2.4 South America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.2.5 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Type (2019-2024)

12.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2019-2024)

12.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2019-2024)

12.4 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Application (2019-2024)

12.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2019-2024)

12.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Nuclear Medicine/Radiopharmaceuticals Picture

Table Product Specifications of Nuclear Medicine/Radiopharmaceuticals

Figure Global Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Types in 2018

Table Nuclear Medicine/Radiopharmaceuticals Types for Major Manufacturers

Figure Diagnostic Picture

Figure Therapeutic Picture

Figure Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Applications in 2018

Figure Oncology Picture

Figure Thyroid Picture

Figure Cardiology Picture

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure France Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure UK Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2014-2024)

Table China Isotope & Radiation Basic Information, Manufacturing Base and Competitors

Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Dongcheng Basic Information, Manufacturing Base and Competitors

Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Jaco Basic Information, Manufacturing Base and Competitors

Table Jaco Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Ciaeriar Basic Information, Manufacturing Base and Competitors

Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors

Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors

Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Type and Applications

Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2017-2018)

Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017

Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2018

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2017-2018)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2018

Figure Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2018

Figure Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2014

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2018

Figure North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019)

Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)

Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2014

Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2018

Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019)

Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)

Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2014

Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2018

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019)

Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)

Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019)

Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2017

Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2018

Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019)

Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries 2018

Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019)

Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries 2018

Figure China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019)

Table South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)

Figure South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2018

Table South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019)

Table South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)

Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2018

Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Colombia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2018

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2014

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2018

Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure UAE Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2014-2019)

Figure Global Diagnostic Sales Growth (2014-2019)

Figure Global Diagnostic Price (2014-2019)

Figure Global Therapeutic Sales Growth (2014-2019)

Figure Global Therapeutic Price (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2014-2019)

Figure Global Thyroid Sales Growth (2014-2019)

Figure Global Cardiology Sales Growth (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Regions (2019-2024)

Figure North America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

Figure Europe Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

Figure Asia-Pacific Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

Figure South America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

Figure Middle East and Africa Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2019-2024)

Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research